Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
21 March 2017
Dear Sirs,
Commercial Information Circular No. 207/2017
The Mainland of China : Public Consultation on "Decisions Concerning Adjusting the Registration Requirements of Imported Pharmaceutical Products"
The China Food and Drug Administration (CFDA) of the People's Republic of China is seeking public comments on "Decisions Concerning Adjusting the Registration Requirements of Imported Pharmaceutical Products". The deadline for submission of comments is 20 April 2017. Please refer to the Appendix (pdf format) for the letter inviting public comments (available in Chinese only). Interested parties may send their comments to CFDA (please refer to the Appendix for contact details).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Ms Helen CHENG)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.